动脉粥样硬化中血管平滑肌细胞的命运与状态
本文综述了利用细胞谱系追踪、单细胞RNA测序和人类基因组学等技术,在实验性和临床动脉粥样硬化中揭示血管平滑肌细胞(VSMC)向其他细胞表型分子重编程的研究进展。当前观点认为,一小部分收缩型VSMC发生命运转换,成为过渡性多潜能细胞,可 adopted 斑块不稳定或稳定状态,相关候选介质正逐渐明确。
要点
- 一小部分收缩型VSMC可发生命运转换,成为过渡性多潜能细胞。
- 这些细胞可 adopted 促进斑块不稳定(炎症、骨化)或稳定(胶原基质沉积)的状态。
- 细胞谱系追踪、单细胞RNA测序和人类基因组学等技术推动了该领域认识。
核心结论
- 一小部分收缩型VSMC发生命运转换,成为过渡性多潜能细胞,可 adopted 斑块不稳定或稳定状态。
- 多种候选介质参与VSMC命运和状态改变,对理解冠心病风险和开发新治疗方式有启示。
研究设计与样本
- 综述性文章,整合细胞谱系追踪、单细胞RNA测序和人类基因组学等技术在实验性和临床动脉粥样硬化中的发现。
- 基于《Circulation》2篇和《Nature Medicine》1篇出版物进行总结。
主要发现
- 收缩型VSMC可转换为过渡性、多潜能细胞,进而 adopted 炎症、骨化或胶原基质沉积等细胞状态。
- 若干候选介质参与VSMC命运和状态改变。
临床怎么用
- 关注VSMC表型转换作为动脉粥样硬化斑块稳定性的潜在干预靶点。
- 利用单细胞技术和谱系追踪识别过渡性VSMC亚群及其调控介质。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vascular smooth muscle cells (VSMCs) have long been associated with phenotypic modulation/plasticity or dedifferentiation. Innovative technologies in cell lineage tracing, single-cell RNA sequencing, and human genomics have been integrated to gain unprecedented insights into the molecular reprogramming of VSMCs to other cell phenotypes in experimental and clinical atherosclerosis. The current thinking is that an apparently small subset of contractile VSMCs undergoes a fate switch to transitional, multipotential cells that can adopt plaque-destabilizing (inflammation, ossification) or plaque-stabilizing (collagen matrix deposition) cell states. Several candidate mediators of such VSMC fate and state changes are coming to light with intriguing implications for understanding coronary artery disease risk and the development of new treatment modalities. Here, we briefly summarize some technical and conceptual advancements derived from 2 publications in Circulation and another in Nature Medicine that, collectively, illuminate new research directions to further explore the role of VSMCs in atherosclerotic disease.
引用
- Miano JM, Fisher EA, Majesky MW, et al. Fate and State of Vascular Smooth Muscle Cells in Atherosclerosis. Circulation. 2021. PMID: 34029141. doi:10.1161/CIRCULATIONAHA.120.049922
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。